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Abstract A nanodiagnostic method using nucleic acid 
sequence-based amplification (NASBA) and gold nano­
particle probes (AuNP probes) was developed for colori­
metric detection of Mycobacterium tuberculosis. The  
primers targeting 16S rRNA were used for the amplification 
of mycobacterial RNA by the isothermal NASBA process. 
The amplicons were hybridized with specific gold nano­
particle probes. The RNA–DNA hybrids were colorimetri­
cally detected by the accumulation of gold nanoparticles. 
Using this method, 10 CFU ml−1 of M. tuberculosis was 
detected within less than 1 h. Results obtained from the 
clinical specimens showed 94.7% and 96% sensitivity and 
specificity, respectively. No interference was encountered in 
the amplification and detection of M. tuberculosis in the 
presence of non-target bacteria, confirming the specificity 
of the method. 
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Introduction 
Rapid detection of Mycobacterium tuberculosis in clinical 
samples is important as a clinical diagnostic tool [1,2]. 
Many clinical methods for detecting and identifying 
M. tuberculosis in samples require analysis of the bacteria’s 
physical characteristics (e.g., acid-fast staining and micro­
scopic detection of bacilli), physiological characteristics 
(e.g., growth on defined media), or biochemical character­
istics (e.g., membrane lipid composition) [3,4]. These 
methods require relatively high concentrations of bacteria 
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in the sample to be detected and are time consuming [5]. 
Assays that detect the presence of nucleic acid derived from 
bacteria in the sample have been preferred because of the 
sensitivity and relative speed of the assays [6,7]. In 
particular, recent advances in functionalizing particles with 
oligonucleotides and tailoring their surface properties have 
paved the way for the development of a series of new and 
practical detection systems [8,9]. Combining new capabil­
ities for controlling particle size and composition with 
versatile surface modification approaches allows for the 
design of optically and chemically encoded nanoparticle 
probes. These probes can be used in molecular detection 
assays with numerous advantages when compared to 
conventional assays [10,11]. For nucleic acid targets, all 
of these properties have allowed for the design of numerous 
assays. The present study describes a rapid and simple 
nanodiagnostic method that detects M. tuberculosis in sputa 
using nucleic acid sequence-based amplification (NASBA) 
and gold nanoparticle probes (Figs. 1, 2). 
Materials and Methods 
Bacterial Strain 
The M. tuberculosis (RIVM) H37Rv strain was provided by 
the PPD Department, Razi Institute, Karaj, Iran. To produce 
specimens with a defined-number of the bacteria, the 
M. tuberculosis bacterium was grown in 7H9 broth medium 
[12]. Escherichia coli (ATCC11775) was used to evaluate 
the specificity of the colorimetric assay and grown in 
tryptic soy broth. 
Specimens 
The 120 sputum samples were collected from 40 patients 
and analyzed as they were received. All specimens were 
decontaminated by the N-acetylcysteine–NaOH procedure 
and cultivated in Löwenstein–Jensen Media [12]. 
Nucleic Acids 
Purified yeast tRNA (Roche, Germany) and E. coli total 
RNA were used to evaluate the impact of non-homologous 
nucleic acids on the specificity of the test. The total RNA 
from E. coli was extracted using RNeasy, Mini kit (Qiagen, 
Germany). 
Preparation of a Broth Culture Containing a Known 
Number of M. tuberculosis 
To produce specimens containing a known number of 
mycobacteria, a culture of M. tuberculosis H37Rv was 
obtained in 7H9 broth medium and adjusted to the turbidity 
equivalent of no. 4 McFarland barium sulfate nephelometer 
standard as described earlier [12]. Fifty microliters of the 
diluted samples contained approximately 105 CFU (i.e., the 
number of colony-forming units). This volume was used for 
lysis and nucleic acid isolation. 
Safety Considerations 
The three elements of containment include laboratory 
practice and technique, safety equipment, and facility 
design [13]. Protection of laboratory workers and the 
Fig. 1 Nucleic acid sequence-based amplification (NASBA). 1 The 
RNA template is targeted with the antisense primer. 2 The primer 
anneals to the specific sequence, and the complement DNA is 
extended by reverse transcriptase against early RNA. 3 The RNA– 
DNA hybrid is treated with RNase H, and the early RNA is 
degenerated. 4 The sense primer-containing T7 promoter is annealed 
to the specific sequence of the newly synthesized single-stranded 
DNA, and the complement DNA strand is extended by reverse 
transcriptase. 5 The double-stranded DNA with T7 promoter, which 
acts as a self-sustained template of the process, is formed. Then, using 
this DNA as template, T7 RNA polymerase synthesizes the sense 
target RNAs. 6 Each of synthesized RNAs can be participated in these 
steps again, and more RNA amplicons are accumulated. 
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Fig. 2 The gold nanoparticle 
assembly and colorimetric as­
say. The gold nanoparticles were 
chemically modified with 5′- or  
3′-(alkanethiol)-capped oligonu­
cleotides (probe). These probes 
flank a specific region on the 
RNA amplicons. The two adja­
cent probes produce a purple 
color when perfectly matched to 
the RNA template. Conversely, 
for the unbound probes, a red 
color of separated gold nano­
particles was observed. 
immediate laboratory environment from exposure to 
M. tuberculosis-contaminated specimens have been provid­
ed by both good microbiological technique and the use of 
appropriate safety equipment. Due to the nature of 
M. tuberculosis, containment level 3 laboratory operational 
and physical requirements have been used for manipulation 
of the live organism. To the best of our knowledge, when 
the assays are used in conjunction with unknown biological 
samples or known mycobacterial samples, all proper 
government safety protocols should be followed [14,15]. 
Nucleic Acid Extraction 
The nucleic acids were extracted from the broth culture and 
sputa as described previously [12]. Briefly, a sample was 
mixed with an equal volume of 2× lysis buffer in a tube. To 
release nucleic acids from the bacteria, the mixture was 
vortexed in the presence of glass beads and few remaining 
intact organisms were heat killed by incubating at 95°C for 
15 min. Generally, 250 μl of the lysate was used in the target 
capture step in which the 16S rRNA attaches non-covalently 
to the specific sequence of an oligonucleotide. The target 
rRNA is captured from the mixture, including 125 μl of  
prepared sample, 125 μl of a target capture solution 
containing 5 pmol of capture oligomer CTAGTCTGCCC 
GTTTT(A)30, and 50 μg of paramagnetic particles with the 
attached immobilized poly(dT)14 probe. Immobilized probes 
were attached using standard carbidiimide chemistry methods 
[16]. The target capture mixture was heated at 60°C for 
about 20 min and then cooled to room temperature to allow 
hybridization. A magnetic field was applied for 5 min to 
attract the magnetic particles with the attached complex 
containing the target RNA to a location on the reaction 
container. The particles were then washed twice with 0.5 ml 
of a washing buffer by resuspending the particles in the 
buffer and repeating the magnetic separation step [17]. 
Oligonucleotides 
The primers were selected from published M. tuberculosis 
rrs gene nucleic acid sequences encoding the 16S rRNA 
(GenBank accession no. BX842576), synthesized by M.W. 
G Biotech Company (Germany). This pair of primers 
amplifies a 580 nucleotide fragment of the target RNA that 
includes the species-specific region for oligonucleotide 
probes to identify the M. tuberculosis (Table 1). The 
reverse primer (rrs R) bears the bacteriophage T7 RNA 
polymerase promoter binding region and preferred 
transcriptional initiation sequence at its 5′ end. The 5′­
or 3′-(alkanethiol)-capped probes (rrs P1 and rrs P2) 
corresponding to two internal regions defined by the 
primers were synthesized by M.W.G Biotech Company 
(Germany) and used for the modification with gold 
nanoparticles. 
Preparation of 3′- or 5′-(Alkanethiol) Oligonucleotide 
Modified Gold Nanoparticles 
Gold nanoparticle probes were prepared following 
literature procedures with minor modifications [18]. 
Briefly, 2.5 OD of (alkanethiol) oligonucleotide (rrs P1, 
10 nmol/OD; rrs P2, 10 nmol/OD) was added to 5 ml of 
13 nm gold nanoparticle solution. After 12 h, the colloid 
solution was brought to 10 mM in phosphate (NaH2PO4/ 
Na2HPO4) by adding 0.1 M, pH 7 concentrated buffer. In 
the subsequent salt aging process, colloids were first 
brought to 0.05 M in NaCl by drop wise addition of 2 M 
NaCl  solution  and allowed  to  stand for  8  h, salted to 0.1  M  
and allowed to age for another 8 h, then salted to 0.2 M for 
standing 8 h, and  finally salted to 0.3  M in NaCl.  To  
remove excess thiol-DNA, the solution was centrifuged 
for 25 min at 16,000×g. Following removal of the 
supernatant, the red oily precipitate was then washed 
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Table 1 Nucleotide sequences of oligonucleotide primers and probes. 
Oligo. name Sequence Location 
rrs F 5′-CATGCAAGTCGAACGGAAAG-3′ 88881–88899 
rrs Ra 5′-AATTCTAATACGACTCACTATAGGGAGAGTATCGCCCGCACGCTCAC-3′ 89442–89461 
rrs P1 5′-HS-(CH2)6-GGTGGAAAGCGCTTTAGCGGT-3′ 89003–89023 
rrs P2 5′-ACCACGGGATGCATGTCTTG-(CH2)3-SH-3′ 88982-89001 
a The T7 promoter sequence is underlined 
with  a solution 0.3  M in KCl  and 20 mM in Tris–HCl 
(pH 8.3). After being washed two times, the colloid was 
redispersed in 5 ml of 0.3  M KCl–0.1% (v/v) Triton  
X-100–20 mM Tris–HCl (pH 8.3) solution and stored in a 
refrigerator (4°C). 
NASBA Process 
For NASBA reaction, washed particles contained target 
RNAs were suspended in 37.5 μl of amplification reagent 
solution (1 mM rUTP, 1 mM rATP, 1 mM rCTP, 1 mM 
rGTP from Fermentas), 0.7 mM each dNTP (Fermentas), 
10 mM KCl, 40 mM Tris–HCl, 12 mM MgCl2, RNase 
inhibitor 12 U (Fermentas), BSA 0.1 μg/μl (Roche), 
DMSO 5% (v/v; Sigma), and DTT 5 mM (Roche), and at 
least two primer oligomers (rrs F and rrs R, each with 
0.2 mM final concentration) and covered with a layer 
(100 μl) of inert oil (Sigma) to prevent evaporation. The 
mixture was incubated at 42°C for 5 min, and then 12.5 μl of  
enzyme mix was added (containing 8 U RevertAidRnaseH plus 
(Fermentas), 40 U T7 RNA polymerase (Fermentas)). The 
mixture was shaken gently and incubated further at 42°C for 
1 h. Negative controls consisted of all of the same reagents 
but substituting for the target with an equal volume of 
water or buffer that contains no target nucleic acid. The 
amplification products were analyzed by agarose gel 
electrophoresis and by gold nanoparticle probes described 
below [12]. 
Fig. 3 UV–vis spectra of gold nanoparticle probes. Series 1, gold 
nanoparticle probes before hybridization with NASBA amplicons; 
series 2, gold nanoparticle probes after hybridization with NASBA 
amplicons. 
Fig. 4 TEM images of gold nanoparticle probes. a Gold nanoparticle 
probes before hybridization with NASBA amplicons; b a two-
dimensional assembly of gold nanoparticle probes after hybridization 
with NASBA amplicons. 
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Fig. 5 Colorimetric detection of 
twofold serial dilutions of 
NASBA products. NASBA was 
performed in the presence of 105 
CFU ml−1, and then NASBA 
product was twofold serially 
diluted before detection using 
gold nanoparticle probes. The 
plotted results are averages of 
triplication analysis. 
Colorimetric Assay Using Gold Nanoparticle Probes 
In a typical experiment, appropriate RNA amplicons were 
added to 100 μl of gold probe solutions containing 50 μl of  
each gold probe. After mixing at 37°C, the solutions were 
immediately measured by colorimetric or UV–vis (Mutispec 
1501 Shimadzu Hyper UV, Japan) [19]. 
Spectra of Gold Nanoparticle Probes 
To 100 μl of gold probe solutions containing 50 μl of each 
gold probe, 2.5 μl of 50 pmol/μl RNA amplicons was 
added. After mixing, the solutions were diluted to 300 μl 
with a 0.1% (v/v) Triton X-100, 20 mM Tris–HCl dilution 
buffer (pH 8.3) and measured for drawing the spectra 
using UV–vis (Mutispec 1501 Shimadzu Hyper UV, 
Japan) [20]. 
Transmission Electron Microscopy of Gold Nanoparticles 
A transmission electron microscopy (TEM; a Hitachi 8100 
model) was used to determine the size and morphology of 
gold nanoparticle probes before and after hybridization with 
NASBA amplicons. 
Validation of the Colorimetric Assay 
For the evaluation of the analytical sensitivity of the test, 
tenfold serial dilutions of M. tuberculosis H37Rv were 
prepared in PBST buffer and subjected to the 16S rRNA 
extraction and the detection procedure described above. For 
the evaluation of the specificity, non-target nucleic acids, 
notably yeast tRNA and total E. coli RNA, were added, 
alone or in the presence of M. tuberculosis 16S rRNA and 
analyzed by the assay [12,21]. 
Results 
UV–vis Spectra of Gold Nanoparticle Probes 
Two spectra resulted from the gold nanoparticle probes 
before and after hybridization with the RNA targets. The 
spectra were shown in Fig. 3 and drawn between 400 to 
Fig. 6 Specificity of the colorimetric assay. The assays were 
performed with non-target nucleic acids such as total E. coli RNA 
and yeast tRNA (at a concentration of 105 CFU ml−1 and 50 μg ml−1, 
respectively). The test was performed on 16S rRNA of M. tuberculosis 
H37Rv as a positive control. The test was performed on H2O as a  
negative control. The plotted results are averages of triplication 
analysis. 
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Fig. 7 Sensitivity of the colori­
metric assay. Tenfold serial 
dilutions of M. tuberculosis 
were prepared and used for 16S 
rRNA extraction and NASBA 
by the above protocols. Then, 
2.5 μl of the NASBA products 
was added to gold nanoparticle 
probes. The plotted results are 
averages of triplication analysis. 
800 nm. Consequently, the wavelength 600 nm was 
selected for the measuring of the tests. 
TEM 
TEM image of the gold nanoparticle probes before 
hybridization with NASBA amplicons have been shown 
in Fig. 4a. Smaller scale image of single layer, two-
dimensional aggregates of the gold nanoparticle probes 
after hybridization with NASBA amplicons have been 
indicated in Fig. 4b. Mixing two gold nanoparticle 
probes (rrs P1, rrs P2) with a solution of RNA target 
resulted in the formation of a polymeric network of 
RNA–DNA-AuNPs with a concomitant red-to-purple 
color change. 
Colorimetric Detection of Twofold Serial Dilutions 
of NASBA Products 
As shown in Fig. 5, the efficiency of the colorimetric 
assay was confirmed by analyzing twofold serial dilutions 
of  the  NASBA  amplicons  of  16S  rRNA  from  
M. tuberculosis. 
Specificity of the Colorimetric Assay 
The specificity of the test was confirmed by the analysis of 
non-target nucleic acids obtained from total E. coli RNA 
and yeast tRNA. The results show no detection of any 
target nucleic acid (Fig. 6). 
Analytical Sensitivity of the Colorimetric Assay 
The analytical sensitivity of the colorimetric assay was 
determined by testing serial dilutions of M. tuberculosis 
H37Rv concentration with a detection limit of 10 CFU ml −1 
in broth media (Fig. 7). From the results, the cutoff value of 
the test was calculated 0.1±0.02 according to the absorbance 
in 600 nm for this assay. 
Clinical Performance of the Colorimetric Assay 
The clinical performance of the assay was determined by 
comparing the test results to those of culture. Included in 
the study were 120 sputum specimens from 40 patients 
received by the laboratory for initial diagnosis or follow-up 
of respiratory mycobacterial infections. The overall results 
Table 2 Comparison of culture 
results with those of the colori- Test and result No. of culture results Sensitivity (%) Specificity (%) 
metric assay. 
Positive Negative 
Gold NASBAa 
a Colorimetric assay (NASBA 
and gold nanoparticle probes) 
Positive 
Negative 
18 
1 
4 
97 
94.7 96 
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presented in Table 2 indicate that the colorimetric assay has 
a sensitivity of 94.7% and specificity of 96% in comparison 
to those of the culture. 
Discussion 
A number of exciting advances have been made in the field 
of nanodiagnostics largely because of advances in nano­
particle synthesis and the control over their surface binding 
properties [21–23]. On the other hand, several amplification 
technologies have been described in the past two decades 
without using thermocycler machine [6]. These advances in 
nanoscience and amplification procedures are having a 
significant impact on many scientific fields and are 
resulting in the development of a variety of rapid detection 
technologies. This impact is particularly large in the field of 
molecular diagnostics, where a number of nanoparticle­
based assays have been introduced for detection, with 
DNA- or RNA-functionalized gold nanoparticles used as 
the target-specific probes [24]. Assays provide an analysis 
of the unique biophysical properties displayed by gold 
nanoparticles and have advantages over conventional 
detection methods [25–28]. 
NASBA is an isothermal amplification technology that 
has proved to be a sensitive and specific method in 
diagnostic microbiology [29]. We have previously de­
scribed the development of a NASBA–ELISA assay for 
the molecular detection of M. tuberculosis [12]. The present 
study is related to the nanomolecular detection of 
M. tuberculosis in biological samples such as sputum using 
a rapid colorimetric assay, contained NASBA process, and 
gold nanoparticle probes. Results obtained by testing 
dilutions of purified M. tuberculosis 16S rRNA indicate 
an analytical sensitivity of 10 CPU ml−1. This high  
sensitivity seen here may be due to several factors: (1) 
The assay detects rRNA, which is present at a level of 
approximately 2,000 copies per cell [30]. This may enhance 
the sensitivity of the assay relative to that of others, which 
detect target sequences present in only a single or very low 
copy number (ten to 16 copies for insertion sequence 
IS6110) [31]. (2) The test is performed directly from 
processed respiratory samples without the need for exten­
sive nucleic acid purification. (3) The detection step is 
hybridization with sensitive gold nanoparticle probes. 
The clinical sensitivity was 94.7% compared with 81.8% 
(in this study) to 90.8% of the culture [32]. In a study of 
this type, the clinical sensitivity of a test is dependent on 
some major factors such as the analytical sensitivity of the 
assay, the sensitivity of the standard (culture technique), the 
distribution of positive specimens (from low positive to 
high positive), and the effects of sample heterogeneity, 
especially in samples with low-positive results. 
The clinical specificity was 96% compared with 96.4% 
(in this study) to 98.9% of the culture [12]. This acceptable 
specificity seen here is because of using a species-specific 
capture oligomer in 16S rRNA isolation step and colorimet­
ric detection of amplified RNAs (obtained from NASBA 
with two specific primers) by gold nanoparticle probes. 
In conclusion, the combination of NASBA with the 
simple yet powerful colorimetric detection of gold nano­
particle assembly offers several advantages (including 
optimal sensitivity and specificity) over other molecular 
assays. This new, gold nanoparticle assembly and nucleic 
acid sequence-based amplification may prove useful in 
molecular diagnosis of infectious diseases and offer great 
potentials for the development of hand-held RNA diag­
nostic devices that could be used to detect pathogens at 
point-of-care [33]. 
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